Evidence map›Paper›PMID 41386641›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2025

Formation and Characterization of Stable Antifouling Colloidal Particles via Surface-Initiated-Photoinduced Electron Transfer-Reversible Addition-Fragmentation Chain-Transfer Polymerization for Standardized Biophysical Measurements.

Jelle B J van den Beukel, Barend van Lagen, Han Zuilhof, Edwin van der Pol

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jelle B J van den BeukelBiomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands.ORCID 0000-0002-9844-2426
Barend van LagenLaboratory of Organic Chemistry, Wageningen University and Research, Stippeneng 4, Wageningen 6708WE, The Netherlands.ORCID 0000-0003-1201-8569
Han ZuilhofLaboratory of Organic Chemistry, Wageningen University and Research, Stippeneng 4, Wageningen 6708WE, The Netherlands.ORCID 0000-0001-5773-8506
Edwin van der PolBiomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands.ORCID 0000-0002-9497-8426

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) are potential biomarkers for various diseases, but EV concentration measurements are difficult to achieve, which often leads to incomparable and irreproducible data. To solve this problem, colloidal particles of known concentration could assist in tracking the sample dilution and determining the volume of the sample in which EVs are counted during the analysis. However, colloidal particles in body fluids suffer from instability due to the nonspecific adsorption of proteins onto their surface. Our aim is to functionalize colloidal particles with antifouling polymer brushes to prevent nonspecific adsorption of proteins from body fluids. To functionalize polystyrene colloidal particles with a diameter of 220 nm, surface-initiated photoinduced electron transfer-reversible addition-fragmentation chain-transfer polymerization was used with three different monomers: nonzwitterionic

Indexed as

BiofoulingPolystyrenesAcrylamidesColloidsElectron TransportExtracellular VesiclesHumansMethacrylatesParticle SizePhosphorylcholinePhotochemical ProcessesPolymerizationSurface PropertiesAcrylamidesColloidsMethacrylatesPhosphorylcholinePolystyrenes

Identifiers

PMID41386641
PMCPMC12751005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.